Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.010 -0.030 (-0.43%)
Official Closing Price Updated: 4:10 PM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Bausch Health to Announce First-Quarter 2023 Results on May 4
Via ACCESSWIRE
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
Via ACCESSWIRE
Bausch Health Announces Changes to its Board of Directors
Via ACCESSWIRE
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
Via ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program
Via ACCESSWIRE
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
Via ACCESSWIRE
Bausch Health Announces Third-Quarter 2022 Results
Via ACCESSWIRE
Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
Via ACCESSWIRE
Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge
Via ACCESSWIRE
Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
Via ACCESSWIRE
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Via ACCESSWIRE
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. 
Via MarketBeat
Exposures Product Safety
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
Via ACCESSWIRE
Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference
Via ACCESSWIRE
Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
Via ACCESSWIRE
Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting
Via ACCESSWIRE
Bausch Health to Announce Third Quarter 2022 Results on Nov. 3
Via ACCESSWIRE
Why These 3 Stocks Are Off to Hot September Starts
Let’s look at what is behind the surprise rise in these three names—and whether they can continue to pace this month’s market rally. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Bausch Health Companies Inc. (NYSE:BHC) Shareholder Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation as announced over potential breaches of fiduciary duties by certain directors at Bausch Health Companies Inc. 
Via SBWire
NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc.
San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc.
San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was... 
Via SBWire
Topics Supply Chain
Exposures COVID-19 Supply Chain
Bausch Health Companies Inc. (NYSE:BHC) Investor Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 08/16/2021 -- Bausch Health Companies Inc is under investigation over potential securities laws in connection with certain financial statements. 
Via SBWire
Topics Supply Chain
Exposures COVID-19 Supply Chain
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.